We are live on ! Find out more
LPPL

Loftus Peak Pty Ltd Portfolio holdings

AUM $781M Turnover 14.29%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$781M
AUM Growth
+$46.5M
Cap. Flow
+$32M
Cap. Flow %
4.09%
Top 10 Hldgs %
60.82%
Holding
28
New
2
Increased
16
Reduced
8
Closed
2
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.2 years
Top 20 Avg Time Held
0.2 years

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$17.1M
2
BB icon
BlackBerry
BB
+$15.8M
3
MRVL icon
Marvell Technology
MRVL
+$14.1M
4
AVGO icon
Broadcom
AVGO
+$13.2M
5
ASML icon
ASML
ASML
+$9.61M

Top Sells

Rank Stock Value
1
ROKU icon
Roku
ROKU
+$18.3M
2
MRNA icon
Moderna
MRNA
+$17.9M
3
AMD icon
Advanced Micro Devices
AMD
+$12.4M
4
META icon
Meta Platforms (Facebook)
META
+$10.8M
5
MSFT icon
Microsoft
MSFT
+$7.85M

Sector Composition

Rank Sector Weight
1 Technology 60.64%
2 Communication Services 18.64%
3 Healthcare 12.08%
4 Consumer Discretionary 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MU icon
26
Micron Technology
MU
$1.05T
$8.76M 1.12%
8,225
-4,289
-34% -$4.07M
2026 Q2
1 quarter
MRNA icon
27
Moderna
MRNA
$94.4B
– –
-255,836
Closed -$17.9M –
ROKU icon
28
Roku
ROKU
$23B
– –
-132,558
Closed -$18.3M –

Similar funds

Loftus Peak Pty Ltd's Q3 2026 Portfolio in Review

As of Q3 2026, Loftus Peak Pty Ltd held 28 positions worth $781M, up 6.3% from $734M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Loftus Peak Pty Ltd deployed $32M of net new capital in Q3 2026, opening 2 new positions and adding to 16 existing holdings. Its largest new stake was AstraZeneca: 102,629 shares worth $16.6M.

By sector, the portfolio is most concentrated in Technology at 61% of assets, up from 58% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $12.4M trimmed.

  • Loftus Peak Pty Ltd's largest Q3 2026 buy was AstraZeneca: 102,629 shares worth $16.6M.
  • Loftus Peak Pty Ltd added most to Marvell Technology in Q3 2026, an estimated $14.1M increase.
  • Loftus Peak Pty Ltd's biggest Q3 2026 reduction was Advanced Micro Devices, cutting an estimated $12.4M.
  • Loftus Peak Pty Ltd fully exited Roku in Q3 2026, selling an estimated $18.3M.
  • Loftus Peak Pty Ltd's ten largest holdings make up 61% of its $781M portfolio in Q3 2026.
  • Loftus Peak Pty Ltd opened 2 new positions and closed 2 in Q3 2026.
  • Loftus Peak Pty Ltd's portfolio value rose 6.3% quarter-over-quarter to $781M.

Based on Loftus Peak Pty Ltd's 13F filing for Q3 2026, filed 15 Oct 2026.